Import Alert Risks for API Manufacturing and ICH Q7 Noncompliance

Strategies for Addressing Import Alerts and ICH Q7 Noncompliance in API Manufacturing In the current regulatory landscape, pharmaceutical manufacturers face increasing scrutiny, especially concerning active pharmaceutical ingredient (API) production. Import…

Import Alert Prevention Through Supplier and CMO Oversight

Preventing Import Alerts Through Enhanced Supplier and CMO Oversight In the complex landscape of pharmaceutical manufacturing, import alerts pose significant risks to operational integrity and product availability. The necessitation of…